Evolutionary and biophysical relationships among the papillomavirus E2 proteins

Frontiers in Bioscience

Volumn 14, Issue 3, 2009, Pages 900-917

  Blakaj, Dukagjin M ^a   Fernandez Fuentes, Narcis ^b   Chen, Zigui ^a   Hegde, Rashmi ^c   Fiser, Andras ^a   Burk, Robert D ^a   Brenowitz, Michael ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

DNA; E2; Electrostatics; Papillomavirus; Protein DNA interactions; Review

Indexed keywords

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

PROTEIN P53; VIRUS PROTEIN;

BIOPHYSICS; EVOLUTION; GENETICS; METABOLISM; PAPILLOMA VIRUS; REVIEW; STATIC ELECTRICITY;

BIOPHYSICS; EVOLUTION; PAPILLOMAVIRIDAE; STATIC ELECTRICITY; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

EID: 63849245059     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3285     Document Type: Article

References (126)

1. E. M. de Villiers, C. Fauquet, T. R. Broker, H. U. Bernard, & H. zur Hausen: Classification of papillomaviruses. Virology 324 (1), 17-27 (2004). (Pubitemid 38737395)
2. A. S. Kadish, R. D. Burk, Y. Kress, S. Calderin, & S. L. Romney: Human papillomaviruses of different types in precancerous lesions of the uterine cervix: Histologic, immunocytochemical and ultrastructural studies. Hum Pathol 17 (4), 384-92 (1986). (Pubitemid 16018576)
3. M. Van Ranst, A. Fuse, P. Fiten, E. Beuken, H. Pfister, R.D. Burk, & G. Opdenakker: Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: Comparison of the genome organizations. Virology 190, 587-596 (1992).
4. A. Narechania, Z. Chen, R. DeSalle, & R. D. Burk: Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol 79 (24), 15503-10 (2005). (Pubitemid 43032332)
5. N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, & C. J. Meijer: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (6), 518-27 (2003). (Pubitemid 36159887)
6. K. Munger & P. M. Howley: Human papillomavirus immortalization and transformation functions. Virus Res 89 (2), 213-28 (2002). (Pubitemid 35351540)
7. A. Hildesheim, M. Schiffman, C. Bromley, S. Wacholder, R. Herrero, A. Rodriguez, M. C. Bratti, M. E. Sherman, U. Scarpidis, Q. Q. Lin, M. Terai, R. L. Bromley, K. Buetow, R. J. Apple, & R. D. Burk: Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93 (4), 315-8 (2001). (Pubitemid 32219819)
8. L. L. Villa, L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, & E. L. Franco: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81 (Pt 12), 2959-68 (2000). (Pubitemid 32000643)
9. L. F. Xi, L. A. Koutsky, D. A. Galloway, J. Kuypers, J. P. Hughes, C. M. Wheeler, K. K. Holmes, & N. B. Kiviat: Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89 (11), 796-802 (1997). (Pubitemid 27242281)
10. R. D. Burk, M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, R. Mortel, P. E. Schwartz, & A. Hildesheim: Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63 (21), 7215-20 (2003). (Pubitemid 37413460)
11. M. Terai & R. D. Burk: Characterization of a novel genital human papillomavirus by overlapping pcr: Candhpv86 identified in cervicovaginal cells of a woman with cervical neoplasia. J Gen Virol 82 (Pt 9), 2035-40. (2001). (Pubitemid 32827583)
12. T. Yamada, M. M. Manos, J. Peto, C. E. Greer, N. Munoz, F. X. Bosch, & C. M. Wheeler: Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71 (3), 2463-72 (1997). (Pubitemid 27078630)
13. A. Eriksson, J. R. Herron, T. Yamada, & C. M. Wheeler: Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the e5 coding segment and the e2 hinge region. J Gen Virol 80 ( Pt 3), 595-600 (1999). (Pubitemid 29101212)
14. V. Bechtold, P. Beard, & K. Raj: Human papillomavirus type 16 e2 protein has no effect on transcription from episomal viral DNA. J Virol 77 (3), 2021-8 (2003). (Pubitemid 36110014)
15. C. Desaintes & C. Demeret: Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 7 (6), 339-47 (1996). (Pubitemid 27380013)
16. O. Danos, M. Katinka, & M. Yaniv: Human papillomavirus 1a complete DNA sequence: A novel type of genome organization among papovaviridae. Embo J 1 (2), 231-6 (1982).
17. M. von Knebel Doeberitz: Papillomaviruses in human disease: Part ii. Molecular biology and immunology of papillomavirus infections and carcinogenesis. Eur J Med 1 (8), 485-91 (1992).
18. L. A. Laimins: The biology of human papillomaviruses: From warts to cancer. Infect Agents Dis 2 (2), 74-86 (1993). (Pubitemid 23252452)
19. H. R. McMurray, D. Nguyen, T. F. Westbrook, & D. J. McAnce: Biology of human papillomaviruses. Int J Exp Pathol 82 (1), 15-33 (2001). (Pubitemid 32578834)
20. R. S. Hegde: The papillomavirus e2 proteins: Structure, function, and biology. Annu Rev Biophys Biomol Struct 31, 343-60. (2002). (Pubitemid 34666837)
21. S. S. Kim, J. K. Tam, A. F. Wang, & R. S. Hegde: The structural basis of DNA target discrimination by papillomavirus e2 proteins. J Biol Chem 275 (40), 31245- 54. (2000).
22. R. S. Hegde & E. J. Androphy: Crystal structure of the e2 DNA-binding domain from human papillomavirus type 16: Implications for its DNA binding-site selection mechanism. J Mol Biol 284 (5), 1479-89. (1998). (Pubitemid 28566082)
23. R. S. Hegde, S. R. Grossman, L. A. Laimins, & P. B. Sigler: Crystal structure at 1.7 a of the bovine papillomavirus-1 e2 DNA-binding domain bound to its DNA target. Nature 359 (6395), 505-12. (1992).
24. D. E. Bussiere, X. Kong, D. A. Egan, K. Walter, T. F. Holzman, F. Lindh, T. Robins, & V. L. Giranda: Structure of the e2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 a. Acta Crystallogr D Biol Crystallogr 54 (2 ( Pt 6)), 1367-76. (1998).
25. R. S. Hegde: Structure of the bpv-1 e2 DNA-binding domain bound to its DNA target. J Nucl Med 36 (6 Suppl), 25S-27S. (1995).
26. C. S. Hines, C. Meghoo, S. Shetty, M. Biburger, M. Brenowitz, & R. S. Hegde: DNA structure and flexibility in the sequence-specific binding of papillomavirus e2 proteins. J Mol Biol 276 (4), 809-18. (1998). (Pubitemid 28122291)
27. D. M. Blakaj, C. Kattamuri, S. Khrapunov, R. S. Hegde, & M. Brenowitz: Indirect readout of DNA sequence by papillomavirus e2 proteins depends upon net cation uptake. J Mol Biol 358 (1), 224-40 (2006).
28. D. U. Ferreiro, M. Dellarole, A. D. Nadra, & G. de Prat-Gay: Free energy contributions to direct readout of a DNA sequence. J Biol Chem 280 (37), 32480-4 (2005). (Pubitemid 41361860)
29. Y. Zhang, Z. Xi, R. S. Hegde, Z. Shakked, & D. M. Crothers: Predicting indirect readout effects in protein- DNA interactions. Proc Natl Acad Sci U S A 101 (22), 8337-41 (2004). (Pubitemid 38736576)
30. G. Dell, K. W. Wilkinson, R. Tranter, J. Parish, R. Leo Brady, & K. Gaston: Comparison of the structure and DNA-binding properties of the e2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J Mol Biol 334 (5), 979-91 (2003). (Pubitemid 37485684)
31. A. A. Antson, J. E. Burns, O. V. Moroz, D. J. Scott, C. M. Sanders, I. B. Bronstein, G. G. Dodson, K. S. Wilson, & N. J. Maitland: Structure of the intact transactivation domain of the human papillomavirus e2 protein. Nature 403 (6771), 805-9. (2000). (Pubitemid 30111845)
32. S. F. Harris & M. R. Botchan: Crystal structure of the human papillomavirus type 18 e2 activation domain. Science 284 (5420), 1673-7. (1999). (Pubitemid 29291378)
33. E. A. Abbate, J. M. Berger, & M. R. Botchan: The x-ray structure of the papillomavirus helicase in complex with its molecular matchmaker e2. Genes Dev 18 (16), 1981-96 (2004). (Pubitemid 39071580)
34. Y. K. Mok, G. de Prat Gay, P. J. Butler, & M. Bycroft: Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 e2 DNA-binding domain. Protein Sci 5 (2), 310-9. (1996). (Pubitemid 26054287)
35. A. D. Nadra, T. Eliseo, Y. K. Mok, C. L. Almeida, M. Bycroft, M. Paci, G. de Prat-Gay, & D. O. Cicero: Solution structure of the hpv-16 e2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold. J Biomol NMR 30 (2), 211-4 (2004).
36. H. Liang, A. M. Petros, R. P. Meadows, H. S. Yoon, D. A. Egan, K. Walter, T. F. Holzman, T. Robins, & S. W. Fesik: Solution structure of the DNA-binding domain of a human papillomavirus e2 protein: Evidence for flexible DNA-binding regions. Biochemistry 35 (7), 2095-103. (1996). (Pubitemid 26071643)
37. S. Veeraraghavan, C. C. Mello, E. J. Androphy, & J. D. Baleja: Structural correlates for enhanced stability in the e2 DNA-binding domain from bovine papillomavirus. Biochemistry 38 (49), 16115-24 (1999). (Pubitemid 129520532)
38. S. Veeraraghavan, C. C. Mello, K. M. Lee, E. J. Androphy, & J. D. Baleja: 1h, 15n, and 13c nmr resonance assignments for the DNA-binding domain of the bpv-1 e2 protein. J Biomol NMR 11 (4), 457-8 (1998). (Pubitemid 128512227)
39. G. de Prat-Gay, A. D. Nadra, F. J. Corrales-Izquierdo, L. G. Alonso, D. U. Ferreiro, & Y. K. Mok: The folding mechanism of a dimeric beta-barrel domain. J Mol Biol 351 (3), 672-82 (2005). (Pubitemid 41021949)
40. N. Zou, B. Y. Lin, F. Duan, K. Y. Lee, G. Jin, R. Guan, G. Yao, E. J. Lefkowitz, T. R. Broker, & L. T. Chow: The hinge of the human papillomavirus type 11 e2 protein contains major determinants for nuclear localization and nuclear matrix association. J Virol 74 (8), 3761-70 (2000). (Pubitemid 30180319)
41. A. A. McBride, H. Romanczuk, & P. M. Howley: The papillomavirus e2 regulatory proteins. J Biol Chem 266 (28), 18411-4 (1991). (Pubitemid 21908095)
42. C. S. Herrington: Human papillomaviruses (hpv) in gynaecological cytology: From molecular biology to clinical testing. Cytopathology 6 (3), 176-89 (1995).
43. H. Rozenberg, D. Rabinovich, F. Frolow, R. S. Hegde, & Z. Shakked: Structural code for DNA recognition revealed in crystal structures of papillomavirus e2-DNA targets. Proc Natl Acad Sci U S A 95 (26), 15194-9. (1998). (Pubitemid 29018675)
44. M. Remm, R. Brain, & J. R. Jenkins: The e2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 20 (22), 6015-21 (1992).
45. J. Z. Lu, Y. N. Sun, R. C. Rose, W. Bonnez, & D. J. McCance: Two e2 binding sites (e2bs) alone or one e2bs plus an a/t-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J Virol 67 (12), 7131-9 (1993). (Pubitemid 23343839)
46. F. Sverdrup & S. A. Khan: Two e2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J Virol 69 (2), 1319-23 (1995).
47. J. M. Zimmerman & L. J. Maher, 3rd: Solution measurement of DNA curvature in papillomavirus e2 binding sites. Nucleic Acids Res 31 (17), 5134-9 (2003). (Pubitemid 37441880)
48. J. Hizver, H. Rozenberg, F. Frolow, D. Rabinovich, & Z. Shakked: DNA bending by an adenine-thymine tract and its role in gene regulation. Proc Natl Acad Sci U S A 98 (15), 8490-5. (2001). (Pubitemid 32678055)
49. H. Lewis & K. Gaston: Magnesium ions enhance the transfer of human papillomavirus e2 protein from nonspecific to specific binding sites. J Mol Biol 294 (4), 885- 96. (1999). (Pubitemid 30000382)
50. T. Tanaka, S. Yokoyama, & Y. Kuroda: Improvement of domain linker prediction by incorporating loop lengthdependent characteristics. Biopolymers (2005).
51. M. B. Swindells, M. W. MacArthur, & J. M. Thornton: Intrinsic phi, psi propensities of amino acids, derived from the coil regions of known structures. Nat Struct Biol 2 (7), 596-603 (1995).
52. C. M. Wilmot & J. M. Thornton: Beta-turns and their distortions: A proposed new nomenclature. Protein Eng 3 (6), 479-93 (1990). (Pubitemid 20290024)
53. K. Gunasekaran, C. Ramakrishnan, & P. Balaram: Beta-hairpins in proteins revisited: Lessons for de novo design. Protein Eng 10 (10), 1131-41 (1997). (Pubitemid 28046174)
54. A. Fiser, M. Feig, C. L. Brooks, 3rd, & A. Sali: Evolution and physics in comparative protein structure modeling. Acc Chem Res 35 (6), 413-21 (2002).
55. C. M. Hebner & L. A. Laimins: Human papillomaviruses: Basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16 (2), 83-97 (2006).
56. G. Dell & K. Gaston: Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci 58 (12-13), 1923-42. (2001).
57. G. Chen & A. Stenlund: Two patches of amino acids on the e2 DNA binding domain define the surface for interaction with e1. J Virol 74 (3), 1506-12 (2000). (Pubitemid 30044101)
58. M. Berg & A. Stenlund: Functional interactions between papillomavirus e1 and e2 proteins. J Virol 71 (5), 3853-63 (1997). (Pubitemid 27172399)
59. Y. Wang, R. Coulombe, D. R. Cameron, L. Thauvette, M. J. Massariol, L. M. Amon, D. Fink, S. Titolo, E. Welchner, C. Yoakim, J. Archambault, & P. W. White: Crystal structure of the e2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor. J Biol Chem 279 (8), 6976-85 (2004). (Pubitemid 38248841)
60. H. Senechal, G. G. Poirier, B. Coulombe, L. A. Laimins, & J. Archambault: Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus e2 affect binding to the long isoform of brd4. Virology 358 (1), 10-7 (2007). (Pubitemid 46048882)
61. M. R. Schweiger, J. You, & P. M. Howley: Bromodomain protein 4 mediates the papillomavirus e2 transcriptional activation function. J Virol 80 (9), 4276-85 (2006).
62. M. K. Baxter, M. G. McPhillips, K. Ozato, & A. A. McBride: The mitotic chromosome binding activity of the papillomavirus e2 protein correlates with interaction with the cellular chromosomal protein, brd4. J Virol 79 (8), 4806-18 (2005). (Pubitemid 40464231)
63. H. U. Bernard: Controls in the papillomavirus life cycle. FEMS Microbiol Immunol 2 (4), 201-5 (1990).
64. Z. Chen, L. Fu, R. Herrero, M. Schiffman, & R. D. Burk: Identification of a novel human papillomavirus (hpv97) related to hpv18 and hpv45. Int J Cancer 121 (1), 193-8 (2007). (Pubitemid 46759490)
65. R. M. Ordonez, A. M. Espinosa, D. J. Sanchez-Gonzalez, J. Armendariz-Borunda, & J. Berumen: Enhanced oncogenicity of asian-american human papillomavirus 16 is associated with impaired e2 repression of e6/e7 oncogene transcription. J Gen Virol 85 (Pt 6), 1433-44 (2004). (Pubitemid 38811424)
66. K. Seedorf, G. Krammer, M. Durst, S. Suhai, & W. G. Rowekamp: Human papillomavirus type 16 DNA sequence. Virology 145 (1), 181-5 (1985). (Pubitemid 15234421)
67. J. L. Parish, A. Kowalczyk, H. T. Chen, G. E. Roeder, R. Sessions, M. Buckle, & K. Gaston: E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol 80 (9), 4580-90 (2006).
68. A. Giannoudis & C. S. Herrington: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193 (3), 295-302 (2001). (Pubitemid 32229859)
69. A. Giannoudis, M. Duin, P. J. Snijders, & C. S. Herrington: Variation in the e2-binding domain of hpv 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84 (8), 1058-63 (2001). (Pubitemid 32448502)
70. M. Durst, A. Kleinheinz, M. Hotz, & L. Gissmann: The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66 ( Pt 7), 1515-22 (1985). (Pubitemid 15070392)
71. E. Schwarz, U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, & H. zur Hausen: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (6006), 111-4 (1985). (Pubitemid 15142033)
72. C. Yee, I. Krishnan-Hewlett, C. C. Baker, R. Schlegel, & P. M. Howley: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119 (3), 361-6 (1985). (Pubitemid 15051884)
73. M. G. Frattini, S. D. Hurst, H. B. Lim, S. Swaminathan, & L. A. Laimins: Abrogation of a mitotic checkpoint by e2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Embo J 16 (2), 318-31 (1997). (Pubitemid 27049389)
74. C. Desaintes, C. Demeret, S. Goyat, M. Yaniv, & F. Thierry: Expression of the papillomavirus e2 protein in hela cells leads to apoptosis. Embo J 16 (3), 504-14 (1997). (Pubitemid 27067780)
75. G. B. Koudelka, S. C. Harrison, & M. Ptashne: Effect of non-contacted bases on the affinity of 434 operator for 434 repressor and cro. Nature 326 (6116), 886-8 (1987). (Pubitemid 17065303)
76. G. B. Koudelka & P. Carlson: DNA twisting and the effects of non-contacted bases on affinity of 434 operator for 434 repressor. Nature 355 (6355), 89-91 (1992).
77. E. L. Rachofsky, J. B. Ross, & R. Osman: Conformation and dynamics of normal and damaged DNA. Comb Chem High Throughput Screen 4 (8), 675-706 (2001). (Pubitemid 34003160)
78. A. K. Aggarwal, D. W. Rodgers, M. Drottar, M. Ptashne, & S. C. Harrison: Recognition of a DNA operator by the repressor of phage 434: A view at high resolution. Science 242 (4880), 899-907 (1988).
79. A. Thain, K. Webster, D. Emery, A. R. Clarke, & K. Gaston: DNA binding and bending by the human papillomavirus type 16 e2 protein. Recognition of an extended binding site. J Biol Chem 272 (13), 8236-42. (1997). (Pubitemid 27147777)
80. R. Stefl, H. Wu, S. Ravindranathan, V. Sklenar, & J. Feigon: DNA a-tract bending in three dimensions: Solving the da4t4 vs. Dt4a4 conundrum. Proc Natl Acad Sci U S A 101 (5), 1177-82 (2004).
81. V. Tchernaenko, H. R. Halvorson, & L. C. Lutter: Topological measurement of an a-tract bend angle: Effect of magnesium. J Mol Biol 341 (1), 55-63 (2004). (Pubitemid 39090634)
82. X. Shui, L. McFail-Isom, G. G. Hu, & L. D. Williams: The b-DNA dodecamer at high resolution reveals a spine of water on sodium. Biochemistry 37 (23), 8341-55 (1998). (Pubitemid 28275453)
83. V Tereshko, G Minasov, & M Egli: A "hydrat-ion" spine in a b-DNA minor groove. J Am Chem Soc 121, 3590-3595 (1999). (Pubitemid 29200267)
84. K. J. McConnell & D. L. Beveridge: Molecular dynamics simulations of b '-DNA: Sequence effects on a-tract-induced bending and flexibility. J Mol Biol 314 (1), 23-40 (2001). (Pubitemid 33097288)
85. K. J. McConnell & D. L. Beveridge: DNA structure: What's in charge? J Mol Biol 304 (5), 803-20 (2000). (Pubitemid 32047084)
86. R. Lavery & B. Pullman: The molecular electrostatic potential, steric accessibility and hydration of dickerson's b-DNA dodecamer d (cpgpcpgpapaptptpcpgpcpg) Nucleic Acids Res 9 (15), 3765-77 (1981).
87. N. V. Hud & J. Plavec: A unified model for the origin of DNA sequence-directed curvature. Biopolymers 69 (1), 144-58 (2003).
88. N. V. Hud & J. Feigon: Characterization of divalent cation localization in the minor groove of the a (n)t (n) and t (n)a (n) DNA sequence elements by (1)h nmr spectroscopy and manganese (ii) Biochemistry 41 (31), 9900-10 (2002). (Pubitemid 34839737)
89. N. V. Hud, P. Schultze, V. Sklenar, & J. Feigon: Binding sites and dynamics of ammonium ions in a telomere repeat DNA quadruplex. J Mol Biol 285 (1), 233-43 (1999). (Pubitemid 29034040)
90. N. V. Hud, V. Sklenar, & J. Feigon: Localization of ammonium ions in the minor groove of DNA duplexes in solution and the origin of DNA a-tract bending. J Mol Biol 286 (3), 651-60 (1999). (Pubitemid 29106207)
91. J. Feigon, S. E. Butcher, L. D. Finger, & N. V. Hud: Solution nuclear magnetic resonance probing of cation binding sites on nucleic acids. Methods Enzymol 338, 400- 20 (2001). (Pubitemid 32666589)
92. MA Young, B. Jayaram, & D. L. Beveridge: Intrusion fo counterions into the spine of hydration in the minor groove of b-DNA: Fractional occupancy of electronegative pockets. J Am Chem Soc 119 (1), 59-69 (1997). (Pubitemid 27064483)
93. X. Shui, C. C. Sines, L. McFail-Isom, D. VanDerveer, & L. D. Williams: Structure of the potassium form of cgcgaattcgcg: DNA deformation by electrostatic collapse around inorganic cations. Biochemistry 37 (48), 16877-87 (1998). (Pubitemid 28566764)
94. L. McFail-Isom, C. C. Sines, & L. D. Williams: DNA structure: Cations in charge? Curr Opin Struct Biol 9 (3), 298-304 (1999). (Pubitemid 29454496)
95. S. Bergqvist, R. O'Brien, & J. E. Ladbury: Site-specific cation binding mediates tata binding protein-DNA interaction from a hyperthermophilic archaeon. Biochemistry 40 (8), 2419-25 (2001). (Pubitemid 32171714)
96. A. A. McBride, R. Schlegel, & P. M. Howley: The carboxy-terminal domain shared by the bovine papillomavirus e2 transactivator and repressor proteins contains a specific DNA binding activity. Embo J 7 (2), 533-9 (1988).
97. J. Faber-Barata, R. Mohana-Borges, & L. M. Lima: Specificity in DNA recognition by a peptide from papillomavirus e2 protein. FEBS Lett 580 (8), 1919-24 (2006).
98. M. T. Record, Jr., C. F. Anderson, & T. M. Lohman: Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: The roles of ion association or release, screening, and ion effects on water activity. Q Rev Biophys 11 (2), 103-78 (1978). (Pubitemid 8373664)
99. M. T. Record, Jr., P. L. deHaseth, & T. M. Lohman: Interpretation of monovalent and divalent cation effects on the lac repressor-operator interaction. Biochemistry 16 (22), 4791-6 (1977). (Pubitemid 8220967)
100. M. T. Record, Jr., M. L. Lohman, & P. De Haseth: Ion effects on ligand-nucleic acid interactions. J Mol Biol 107 (2), 145-58 (1976).
101. K. S. Byun & D. L. Beveridge: Molecular dynamics simulations of papilloma virus e2 DNA sequences: Dynamical models for oligonucleotide structures in solution. Biopolymers 73 (3), 369-79 (2004). (Pubitemid 38222212)
102. D. Djuranovic & B. Hartmann: DNA fine structure and dynamics in crystals and in solution: The impact of bi/bii backbone conformations. Biopolymers 73 (3), 356-68 (2004). (Pubitemid 38222211)
103. D. Djuranovic & B. Hartmann: Molecular dynamics studies on free and bound targets of the bovine papillomavirus type i e2 protein: The protein binding effect on DNA and the recognition mechanism. Biophys J 89 (4), 2542-51 (2005). (Pubitemid 41401042)
104. D. Djuranovic, C. Oguey, & B. Hartmann: The role of DNA structure and dynamics in the recognition of bovine papillomavirus e2 protein target sequences. J Mol Biol 339 (4), 785-96 (2004). (Pubitemid 38686345)
105. A. Thain, O. Jenkins, A. R. Clarke, & K. Gaston: Cpg methylation directly inhibits binding of the human papillomavirus type 16 e2 protein to specific DNA sequences. J Virol 70 (10), 7233-5 (1996). (Pubitemid 26307443)
106. K. Kim, P. A. Garner-Hamrick, C. Fisher, D. Lee, & P. F. Lambert: Methylation patterns of papillomavirus DNA, its influence on e2 function, and implications in viral infection. J Virol 77 (23), 12450-9 (2003). (Pubitemid 37430642)
107. F. Rosl, A. Arab, B. Klevenz, & H. zur Hausen: The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol 74 ( Pt 5), 791-801 (1993). (Pubitemid 23154279)
108. B. Jayaram, K. McConnell, S. B. Dixit, A. Das, & D. L. Beveridge: Free-energy component analysis of 40 protein-DNA complexes: A consensus view on the thermodynamics of binding at the molecular level. J Comput Chem 23 (1), 1-14 (2002). (Pubitemid 34063125)
109. L. Jen-Jacobson: Protein-DNA recognition complexes: Conservation of structure and binding energy in the transition state. Biopolymers 44 (2), 153-80 (1997).
110. L. L. Villa, K. A. Ault, A. R. Giuliano, R. L. Costa, C. A. Petta, R. P. Andrade, D. R. Brown, A. Ferenczy, D. M. Harper, L. A. Koutsky, R. J. Kurman, M. Lehtinen, C. Malm, S. E. Olsson, B. M. Ronnett, F. E. Skjeldestad, M. Steinwall, M. H. Stoler, C. M. Wheeler, F. J. Taddeo, J. Yu, L. Lupinacci, R. Railkar, R. Marchese, M. T. Esser, J. Bryan, K. U. Jansen, H. L. Sings, G. M. Tamms, A. J. Saah, & E. Barr: Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine (2006).
111. D. M. Harper, E. L. Franco, C. M. Wheeler, A. B. Moscicki, B. Romanowski, C. M. Roteli-Martins, D. Jenkins, A. Schuind, S. A. Costa Clemens, & G. Dubin: Sustained efficacy up to 4.5 years of a bivalent l1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367 (9518), 1247-55 (2006).
112. L. L. Villa, R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. E. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. J. Kurman, B. M. Ronnett, M. H. Stoler, A. Ferenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, & E. Barr: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase ii efficacy trial. Lancet Oncol 6 (5), 271-8 (2005). (Pubitemid 40590263)
113. D. R. Lowy & J. T. Schiller: Prophylactic human papillomavirus vaccines. J Clin Invest 116 (5), 1167-73 (2006).
114. J. L. Brandsma, M. Shlyankevich, L. Zhang, M. D. Slade, E. C. Goodwin, W. Peh, & A. B. Deisseroth: Vaccination of rabbits with an adenovirus vector expressing the papillomavirus e2 protein leads to clearance of papillomas and infection. J Virol 78 (1), 116-23 (2004). (Pubitemid 37549724)
115. A. de Jong, M. I. van Poelgeest, J. M. van der Hulst, J. W. Drijfhout, G. J. Fleuren, C. J. Melief, G. Kenter, R. Offringa, & S. H. van der Burg: Human papillomavirus type 16-positive cervical cancer is associated with impaired cd4+ t-cell immunity against early antigens e2 and e6. Cancer Res 64 (15), 5449-55 (2004). (Pubitemid 39006568)
116. M. L. Cerutti, L. M. Zarebski, G. de Prat Gay, & F. A. Goldbaum: A viral DNA-binding domain elicits anti-DNA antibodies of different specificities. Mol Immunol 42 (3), 327-33 (2005). (Pubitemid 39626765)
117. P. Rice, I. Longden, & A. Bleasby: Emboss: The european molecular biology open software suite. Trends Genet 16 (6), 276-7 (2000).
118. J. D. Thompson, D. G. Higgins, & T. J. Gibson: Clustal w: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice. Nucleic Acids Res 22 (22), 4673-80 (1994). (Pubitemid 24354800)
119. C. D. Livingstone & G. J. Barton: Protein sequence alignments: A strategy for the hierarchical analysis of residue conservation. Comput Appl Biosci 9 (6), 745-56 (1993). (Pubitemid 24016574)
120. A. Fiser & A. Sali: Modeller: Generation and refinement of homology-based protein structure models. Methods Enzymol 374, 461-91 (2003). (Pubitemid 37531821)
121. A. Sali & T. L. Blundell: Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234 (3), 779-815 (1993). (Pubitemid 24007801)
122. M. J. Sippl: Recognition of errors in threedimensional structures of proteins. Proteins 17 (4), 355-62 (1993). (Pubitemid 23358545)
123. R. A. Laskowski, D. S. Moss, & J. M. Thornton: Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231 (4), 1049-67 (1993). (Pubitemid 23209879)
124. R. B. Russell & G. J. Barton: Multiple protein sequence alignment from tertiary structure comparison: Assignment of global and residue confidence levels. Proteins 14 (2), 309-23 (1992).
125. K. Schleinkofer, U. Wiedemann, L. Otte, T. Wang, G. Krause, H. Oschkinat, & R. C. Wade: Comparative structural and energetic analysis of ww domain-peptide interactions. J Mol Biol 344 (3), 865-81 (2004). (Pubitemid 39480704)
126. N. A. Baker, D. Sept, S. Joseph, M. J. Holst, & J. A. McCammon: Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98 (18), 10037-41 (2001). (Pubitemid 32802969)